RightHill Ventures

RightHill Ventures is a venture capital firm established in 2022 and located in Providence, Rhode Island. The company focuses on providing capital and support to early-stage technology companies, aiming to foster innovation and growth in the tech sector. By investing in promising startups, RightHill Ventures plays a vital role in nurturing new ideas and technologies, contributing to the overall development of the entrepreneurial ecosystem.

Thorne Sparkman

Managing Director

2 past transactions

VoltServer

Series B in 2023
VoltServer Inc. is a company that manufactures and supplies innovative electrical power distribution products, leveraging its patented Digital Electricity technology. This technology enables the delivery of touch-safe electricity through standard data cables, significantly improving the cost, speed, power, distance, efficiency, and flexibility of electrical installations compared to traditional methods. VoltServer's solutions are applicable in various sectors, including telecommunications, data centers, renewable energy, and electric vehicles. The company's products support wireless densification, intelligent buildings, and indoor agriculture. VoltServer began shipping its products in 2015 and has since been deployed in numerous large venues, such as sports stadiums, office buildings, hotels, and medical facilities. Founded in 2011, VoltServer is based in East Greenwich, Rhode Island, with an additional office in Basingstoke, United Kingdom.

MindImmune

Series A in 2022
MindImmune Therapeutics, Inc. is a pharmaceutical company focused on developing innovative drugs that target the immune system to address diseases of the central nervous system, including Alzheimer’s and Huntington’s diseases, as well as pain and psychiatric disorders. Recognizing the critical role of immune system dysfunction in brain health, MindImmune aims to leverage this connection to create effective therapeutic options. Founded in 2016 and headquartered in Kingston, Rhode Island, the company is establishing partnerships with the George & Anne Ryan Institute for Neuroscience at the University of Rhode Island to enhance its research and development efforts. MindImmune is committed to advancing its drug development programs within the growing Rhode Island academic neuroscience ecosystem.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.